Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

I think including the 20% is probably the

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
tradeherpete Member Profile
 
Followed By 25
Posts 2,297
Boards Moderated 0
Alias Born 03/20/14
160x600 placeholder
Anavex Life Sciences to Present at the H.C. Wainwright Global Life Sciences Conference GlobeNewswire Inc. - 3/4/2021 7:00:00 AM
Anavex Life Sciences Announces Participation at Upcoming Worldwide National Institutes of Health (NIH) Panel at Rare Disease ... GlobeNewswire Inc. - 2/22/2021 7:00:00 AM
Nextech AR (OTCQB: NEXCF) $13 million Deal, Guidance to $50-60 Million, $8.60 Valuation InvestorsHub NewsWire - 2/22/2021 6:18:20 AM
Anavex Life Sciences Announces Participation at Precision in Clinical Trials Virtual Summit GlobeNewswire Inc. - 2/19/2021 7:00:00 AM
Anavex Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference on February 25, 2021 GlobeNewswire Inc. - 2/18/2021 7:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 4:07:35 PM
Nextech AR (OTCQB: NEXCF) 2021 Guidance $50-60 Million Closes 2020 with $20 million. InvestorsHub NewsWire - 2/12/2021 6:26:34 AM
Anavex Life Sciences EPS in-line Seeking Alpha - 2/11/2021 7:22:45 AM
Anavex Life Sciences Reports Fiscal 2021 First Quarter Financial Results And Business Outlook GlobeNewswire Inc. - 2/11/2021 7:00:00 AM
Anavex Life Sciences to Announce Fiscal 2021 First Quarter Financial Results and Business Outlook on Thursday, February 11, 2... GlobeNewswire Inc. - 2/8/2021 7:00:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/2/2021 3:17:03 PM
Anavex Life Sciences Receives Michael J. Fox Foundation Grant for Clinical Study of ANAVEX®2-73 (blarcamesine) in People wit... GlobeNewswire Inc. - 1/11/2021 7:00:00 AM
Anavex Life Sciences to Present at the H.C. Wainwright Virtual BioConnect Conference GlobeNewswire Inc. - 1/6/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2021 2:28:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2021 2:26:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2021 2:25:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2021 2:23:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2021 2:20:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/28/2020 5:29:22 PM
Annual Report (10-k) Edgar (US Regulatory) - 12/28/2020 5:28:26 PM
Anavex Life Sciences Reports Fiscal 2020 Year End Financial Results And Clinical Program Updates GlobeNewswire Inc. - 12/28/2020 7:00:00 AM
Biotech Report; Upcoming FDA Reviews and Promising Pipelines InvestorsHub NewsWire - 12/22/2020 8:20:00 AM
Anavex Life Sciences to Announce Fiscal 2020 Year End Financial Results December 28th, 2020 GlobeNewswire Inc. - 12/22/2020 7:00:00 AM
Anavex Life Sciences Announces Webinar on Rett Syndrome and ANAVEX®2-73 (Blarcamesine) Phase 2 Data hosted by Ladenburg Thal... GlobeNewswire Inc. - 12/21/2020 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/15/2020 7:09:21 AM
tradeherpete   Saturday, 08/04/18 11:34:48 AM
Re: XenaLives post# 161471
Post # of 302265 
Quote:
I think including the 20% is probably the P2b part, then the population will be recharacterized for the P3.

Why wouldn’t they undergo any re-characterization they would receive in the /3, in the 2b? And if not how would they be re-characterized?

I don’t disagree with you, it’s just I have no idea how any of this works but you asked me…


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
© 2021 InvestorsHub.com, Inc.
Consent Preferences




Ticker News is disabled